PAG
GSK icon

Paladin Advisory Group’s GSK GSK Stock Holding History

Paladin Advisory Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-326
Closed -$17K – 275
2022
Q2 		$17K Buy
+326
New +$18K 0.01% 210
2022
Q1 		– Sell
-318
Closed -$17K – 363
2021
Q4 		$17K Buy
+318
New +$16.5K 0.01% 219

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Paladin Advisory Group's GSK Position: Q2 2022 in Review

Paladin Advisory Group sold out of GSK (GSK) in Q2 2022, closing a stake of 321 shares — an estimated $17.7K sold.

Paladin Advisory Group first reported a position in GSK in Q1 2022 and held it in 1 quarter. The position peaked at $17K in Q1 2022. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

  • Paladin Advisory Group reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
  • Paladin Advisory Group sold 321 GSK shares in Q2 2022, an estimated $17.7K.
  • Paladin Advisory Group first reported a position in GSK in Q1 2022 and held it in 1 quarter.
  • Paladin Advisory Group's GSK position peaked at $17K in Q1 2022.
  • 900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Paladin Advisory Group's 13F filing for Q2 2022, filed 6 Jul 2022.